Fidelity European Trust: Resilience in difficult markets – a half-year report

Hardman & Co
[shareaholic app="share_buttons" id_name="post_below_content"]

In our recent note, Eight questions for the AGM on 10 May 2022 | Hardman & Co (hardmanandco.com), we touched on the rapidly changing landscape after the extraordinary bull run experienced in most global equity markets since the 2008 GFC. In this note, we take stock, analyse how Fidelity European Trust plc (LON:FEV) has performed YTD and highlight a few of its investments as key examples of its philosophy and process. Despite the tough start, it is worth reiterating that FEV’s focus is on stock-picking and downside risk, and this should reassure investors that FEV is continuing to add value to investors over the long term.

  • Difficult year so far: As of 26 September, Fidelity European Trust’s share price is down 19.5% YTD, slightly underperforming the index, which is down 17.4%. The discount to NAV is 11.7%. We remain confident about FEV’s bottom-up investment approach and long-term performance, despite the current macro challenges.
  • Investment discipline: In this report, we focus on three of the fund’s investments as prime examples of FEV’s key investment tenets: a bottom-up process, which seeks out those companies able to grow dividends sustainably over a three- to five-year horizon. The result is only short periods of underperformance over FEV’s history.
  • Valuation: 99.9% of investments are valued using quoted prices in active markets (95% is realisable within five days). The NAV is “real” – so any discount is anomalous. The current discount of 11.7% is above long-run averages, and is below FEV’s peer group, but not by much, despite the better performance.
  • Risks: FEV has seen periods of underperformance when its investment style has been out of favour – typically, when the market’s preference has been for lower-quality, more cyclical stocks. Worries around performance are bound to resurface, given the current rotation, as well as the outlook for interest rates and inflation.
  • Investment summary: Fidelity European Trust has outperformed its peers, benchmarks and UK indices over most time periods. Sentiment to Europe may vary – although we believe there is a perception vs. reality issue here. The current market jitters may lead to some return volatility, but, in our view, FEV’s long-term track record in a wide range of market conditions should reassure investors that the fund will not deviate from its tried-and-tested, long-term process and philosophy.

DOWNLOAD THE FULL REPORT

Share on:
Find more news, interviews, share price & company profile here for:

European equities mark an unexpected high as sector leadership broadens

European equities reached a fresh high led by technology, industrials and healthcare in a rally defined more by conviction than speculation.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Pharma shifts and tech resilience shape a new mood in European equities

European stocks are catching lift from pharma reshuffles and tech rebounds even as Lufthansa’s bold cost cuts raise the stakes for execution.

A ruling in Rhode Island sets a new tone for European utilities

A U.S. court ruling reignited European utilities, retail spin-offs drew attention, and chip equipment guidance cast a shadow, setting a distinctive tone for investors.

European equities edge higher as France faces a test of stability

European equities find support from Fed-cut hopes, even as a crucial no-confidence vote in France threatens to reshape sentiment.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

Search

Search